Humana — Feb 11, 2026 release
Fiscal 2025 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-26-000005
Showing in the filing
GAAP EPS
“at least $8.89”
Period
FY2026
Measure
GAAP-tied
Source
Prose
All guidance in this release · 7
GAAP EPS for FY2026
“at least $8.89”
GAAP for FY2026
“at least $8.89”
Adjusted EPS for FY2026
“at least $9.00”
Diluted earnings per share (EPS) - Adjusted … for FY2026
“at least $9.00”
Individual Medicare Advantage membership gro… for FY2026
“approximately 25 percent”
Medicaid footprint expansion (Georgia and Te… for FY2027
“expected to launch in 2027”
Diluted earnings per share (EPS) - GAAP for FY2026
“at least $8.89”
Exhibit 99.1 · the passage around this item
… earlier in the release
Box 1438 Louisville, KY 40202 http://www.humana.com FOR MORE INFORMATION CONTACT: Lisa Stoner Humana Investor Relations (502) 580-2652 e-mail: LStamper@humana.com Mark Taylor Humana Corporate Communications (317) 753-0345 e-mail: MTaylor108@humana.com Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance • Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations • 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' • Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of mitigation • Anticipates FY 2026 individual Medicare Advantage membership growth of 'approximately 25 percent' over 2025; driven by new sales and improved retention from the company's customer-led benefit strategy and changes to its customer service approach • Continued growth in the CenterWell and Medicaid platforms ◦ Growth of 100,600 patients, or over 25 percent, in CenterWell Senior Primary Care during 2025, including approximately 32,000 patients associated with the acquisition of The Villages Health • Expanded Medicaid footprint, which now spans 13 states, including Georgia and Texas which are expected to launch in 2027 • Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 8:00 a.m. ET question and answer session to discuss its financial results for the quarter and expectations for future earnings LOUISVILLE, KY (February 11, 2026) – Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share (EPS) for the quarter ended December 31, 202
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.